Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Pak Med Assoc ; 64(12): 1398-404, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25842586

RESUMO

OBJECTIVE: To study the efficacy of a low-cost heating pack device used for thermotherapy in the treatment of cutaneous leishmaniasis. METHODS: The study was conducted at the Department of Dermatology, Civil Hospital Sukkur, Pakistan, from April 20, 2012, to January 3, 2013. Thermotherapy with Hand-Held Exothermic Crystallisation Therapy for cutaneous leishmaniasis was performed on each lesion of the participating subjects at an average initial temperature of 51.6°C for 3 minutes daily for 7 days. Patients were followed regularly for 6 months after the therapy. SPSS 20 was used for statistical analysis. RESULTS: Even though all 27 patients completed 1 week of thermotherapy, only 23(85.2%) patients could be evaluated for full treatment response since 4(14.8%) were lost to complete follow-up. By the final 180-day evaluation, 19 (83%) patients had been cured. Applications were well tolerated with no side effects. CONCLUSION: The devise was a convenient, safe, non-toxic and effective treatment for cutaneous leishmaniasis at a fraction of the cost of standard antimonial treatment. Further studies are needed to certify its safety and efficacy as monotherapy for the condition.


Assuntos
Hipertermia Induzida/economia , Leishmaniose Cutânea/terapia , Adolescente , Adulto , Criança , Pré-Escolar , Custos e Análise de Custo , Feminino , Humanos , Hipertermia Induzida/instrumentação , Hipertermia Induzida/métodos , Lactente , Leishmaniose Cutânea/economia , Masculino , Pessoa de Meia-Idade , Paquistão , Projetos Piloto , Adulto Jovem
2.
Am J Trop Med Hyg ; 75(1): 126-32, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16837718

RESUMO

Iron and zinc deficiencies are common in developing countries and supplementation is one way of reversing these deficiencies. The objective of this randomized, placebo-controlled clinical trial was to identify the effect of daily supplementation with iron, zinc, and iron plus zinc on the morbidity experience of 855 children 0.5-15 years of age in Peru. Single nutrient supplementation with zinc reduced diarrhea morbidity by 23% in all children. In older children (more than five years of age), iron supplementation increased morbidity due to Plasmodium vivax and diarrhea. In younger children, iron combined with zinc provided protection against P. vivax malaria, but also interfered with some of the diarrhea protection associated with zinc supplementation. No statistically significant effect was observed of either supplement on incidence of respiratory infection or anthropometric indices. Iron and zinc deficiencies should be remedied, and combined supplementation may be a good option, particularly in younger children in P. vivax malaria-endemic areas, although local endemicity and species-specific prevalence should be considered carefully when designing any supplementation program involving iron in a malaria-endemic area.


Assuntos
Diarreia/prevenção & controle , Suplementos Nutricionais/normas , Ferro/administração & dosagem , Malária/prevenção & controle , Infecções Respiratórias/prevenção & controle , Sulfato de Zinco/administração & dosagem , Adolescente , Criança , Pré-Escolar , Diarreia/epidemiologia , Método Duplo-Cego , Combinação de Medicamentos , Humanos , Lactente , Ferro/farmacologia , Malária/epidemiologia , Peru/epidemiologia , Infecções Respiratórias/epidemiologia , Fatores de Tempo , Resultado do Tratamento , Sulfato de Zinco/farmacologia
4.
PLoS Negl Trop Dis ; 7(5): e2196, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23658851

RESUMO

Thermotherapy is an accepted alternative therapy for new-world cutaneous leishmaniasis, but current heat-delivery modalities are too costly to be made widely available to endemic populations. We adapted a low-cost heat pack named the HECT-CL device that delivers safe, reliable, and renewable conduction heat. 25 patients with cutaneous leishmaniasis completed treatment with the device at an initial temperature of 52°C ± 2°C for 3 minutes to each lesion, repeated daily for 7 days, and were followed up for 6 months by direct observation. The overall definitive clinical cure rate was 60%. Concurrently, 13 patients meeting minimally significant exclusion criteria received identical compassionate use treatment with a cumulative definitive cure rate of 68.4%, 75% for those who had experienced CL relapse after prior antimonial treatment. Therapy was well tolerated. Reversible second-degree burns occurred in two patients and no bacterial super-infections were observed. HECT-CL is a promising treatment and deserves further study to verify its safety and efficacy as adjuvant and mono- therapy.


Assuntos
Hipertermia Induzida/métodos , Leishmaniose Cutânea/terapia , Adolescente , Adulto , Idoso , Queimaduras/epidemiologia , Queimaduras/patologia , Criança , Custos e Análise de Custo , Feminino , Humanos , Hipertermia Induzida/efeitos adversos , Hipertermia Induzida/economia , Hipertermia Induzida/instrumentação , Masculino , Pessoa de Meia-Idade , Peru , Projetos Piloto , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA